Clinical trials: Persistent Allergic Rhinitis
Allergic Rhinitis
Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic Rhinitis
To assess the efficacy of the study product Noex in the treatment of allergic rhinitis by means of the Nasal Index Score (NIS) after 4 weeks of treatment with the drug.
- Trial name
- NOEX (NCT01022047)
- Testing
- Noex, Budecort Aqua
- Where
- Brazil
- Volunteers
- 280 people, healthy volunteers welcome
- Sponsor
- Eurofarma Laboratorios S.A.
Allergic Rhinitis
Anti-inflammatory H1 Antihistamines Allergic Rhinitis
The main purpose of the treatment of persistent allergic rhinitis is to improve symptoms and patients' quality of life and prevent the development of asthma.
- Trial name
- NCT02507635
- Testing
- Levocetirizine, Desloratadine
- Volunteers
- 115 people, healthy volunteers welcome
- Sponsor
- Iuliu Hatieganu University of Medicine and Pharmacy